Cynomolgus Monkey Serum (NHP-BP001)

Tag: Cynomolgus Monkey, Serum
- Cynomolgus monkey is frequently used in scientific research, especially those involved in neuroscience and disease. This available serum product is collected from cynomolgus monkeys. The sample is high-quality and has been confirmed as negative for Herpes B Virus, retroviruses, SIV, SRV, and STLV. and can be used to perform a number of common biochemical experiments for desired research purposes.
Detailed Product Description
- Source: Healthy cynomolgus monkey
- Purity: No hemolysis or clotting.
- Applications: Suitable for various research fields including biomarker research, pharmacology, and toxicology.
- Storage Conditions: Store at -20 °C or -80 °C. Avoid freeze-thaw cycle.
Technical Specifications
- Collection Method: Serum is collected from rigorously screened healthy donors, and the collection process strictly adheres to animal welfare requirements. Obtained through centrifugation processing of non-anticoagulated whole blood, serum does not contain fibrinogen or other clotting factors and serves as a primary source for biomarkers.
- Quality Control: Strict accordance with biomedical standards.
- Available Formats: Frozen
-
Q 1: How is Cynomolgus Monkey Serum tested for pathogens, and what certifications are important?
A: Testing a quality Cynomolgus Monkey Serum for a wide gamut of pathogens, such as herpes B virus, SIV, SRV, STLV, etc., is mandatory. At the very least, some of the well-reputed certification bodies, including USDA or its equivalents, could provide a little solace to the researchers in such aspects that would ensure the minimum ethical treatment of animals and at least a certain level of standards safety and quality of the produced serum.
There are currently no customer reviews or questions for Cynomolgus Monkey Serum (NHP-BP001). Click the button below to contact us or submit your feedback about this product.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Enter your email here to subscribe.
SubmitFollow us on
